Roivant Sciences Ltd.
ROIV Healthcare Biotechnology
Roivant Sciences Ltd.’s revenue for fiscal 2026 (year ended March 2026) was $8.3 million, down 71.6% from fiscal 2025.
- Revenue
- −33.6%
- EPS
- +21.2%
- Free cash flow
- −30.0%
Quarter to June 2026, against a year earlier
Follow ROIV
Alert me
Roivant Sciences Ltd. (ROIV) Operating margin
Roivant Sciences Ltd.'s operating margin over the twelve months to 30 June 2026 was −7,914.8%, down 1679.1 percentage points from fiscal 2026 (−6,235.7%). Over the past ten years it has ranged from −6,235.7% (fiscal 2026) to 13,746.9% (fiscal 2024) — the current reading is the lowest in ten years. That is below the Biotechnology industry median of 0.00% and below the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2026 | −6,235.7% | (2,782.37) |
| FY2025 | −3,453.3% | (17,200.25) |
| FY2024 | 13,746.9% | 15,664.88 |
| FY2023 | −1,918.0% | 526.87 |
| FY2022 | −2,444.8% | 2,055.70 |
| FY2021 | −4,500.5% | (4,500.52) |
| FY2020 | 0.00% | — |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Jun 2026 | −25,380.9% | (41,858.71) |
| Mar 2026 | 16,477.8% | 33,443.91 |
| Dec 2025 | −16,966.1% | 2,526.74 |
| Sep 2025 | −19,492.9% | (6,362.82) |
| 21 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| RPRX Royalty Pharma PLC compare | 57.1% |
| GMAB Genmab A/S Sponsored ADR compare | 26.0% |
| ALNY Alnylam Pharmaceuticals, Inc. compare | 19.5% |
| ONC BeOne Medicines Ltd. - Sponsored ADR compare | 17.8% |
| INCY Incyte Corporation compare | 10.4% |
| INSM Insmed, Inc. compare | −37.1% |
| BNTX BioNTech SE Sponsored ADR compare | −79.0% |
| RVMD Revolution Medicines, Inc. compare | −805.8% |
| ROIV Roivant Sciences Ltd. | −7,914.8% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on ROIV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- The full statement